Dr Reddys Laboratories Ltd Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Cr

Consolidate Quarterly Results

Mar'26

Dec'25

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Net Sales

7,546.40

8,753.40

8,828.30

8,572.10

8,528.40

8,381.20

8,038.20

Other Operating Income

0.00

Total Operating income

7,546.40

8,753.40

8,828.30

8,572.10

8,528.40

8,381.20

8,038.20

Raw Material Cost

1,198.60

1,825.50

1,441.30

2,035.80

1,716.50

1,452.60

1,287.20

Purchase of Finished goods

1,657.70

1,542.10

1,745.90

1,215.90

1,127.50

1,050.70

1,282.80

(Increase) / Decrease In Stocks

356.40

-272.30

-63.50

-444.20

6.00

78.20

-203.30

Employee Cost

1,446.80

1,588.50

1,452.10

1,503.50

1,400.60

1,366.50

1,399.20

Power Cost

0.00

Manufacturing Expenses

0.00

Selling and Distribution Expenses

0.00

Other Expenses

2,504.40

2,182.10

2,242.60

2,087.50

2,279.90

2,160.20

2,195.80

Total Expenditure (Excl Depreciation)

7,163.90

6,865.90

6,818.40

6,398.50

6,530.50

6,108.20

5,961.70

Operating Profit (PBDIT) excl Other Income

382.50

1,887.50

2,009.90

2,173.60

1,997.90

2,273.00

2,076.50

Other Income

475.40

268.80

323.90

290.30

522.10

150.20

307.50

Operating Profit (PBDIT)

857.90

2,156.30

2,333.80

2,463.90

2,520.00

2,423.20

2,384.00

Interest

105.70

94.40

90.70

83.00

65.60

81.70

75.70

Exceptional Items

0.00

Gross Profit (PBDT)

752.20

2,061.90

2,243.10

2,380.90

2,454.40

2,341.50

2,308.30

Depreciation

557.10

521.00

504.60

476.10

454.70

471.40

397.00

Profit Before Tax

199.70

1,543.20

1,744.80

1,905.00

2,005.20

1,874.30

1,917.40

Tax

-21.60

353.60

408.00

495.10

418.50

470.10

575.50

Provisions and contingencies

0.00

Profit After Tax

216.70

1,187.30

1,330.50

1,409.70

1,581.20

1,400.00

1,335.80

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

216.70

1,187.30

1,330.50

1,409.70

1,581.20

1,400.00

1,335.80

Share in Profit of Associates

4.60

2.30

6.30

0.20

5.50

4.20

6.10

Minority Interest

0.40

-20.30

-10.30

-8.20

-6.60

-9.50

86.20

Other related items

0.00

Consolidated Net Profit

220.90

1,209.90

1,347.10

1,418.10

1,593.30

1,413.70

1,255.70

Equity Capital

83.50

83.40

Face Value

1.0

5.0

Reserves

0.00

Earnings per share (EPS)

2.65

14.49

16.13

16.98

19.1

16.95

15.06

Diluted Earnings per share

2.65

14.52

16.18

17.02

19.1

16.94

15.05

Operating Profit Margin (Excl OI)

5.09%

21.63%

22.83%

25.44%

23.49%

27.19%

25.9%

Gross Profit Margin

10.01%

23.63%

25.48%

27.86%

28.85%

28.01%

28.8%

PAT Margin

2.94%

13.63%

15.18%

16.5%

18.65%

16.8%

16.74%

Public Share Holdings (%)

0.0%

Pledged Promotor Holding (%)

0.0%

Quarterly Analysis Highlights - QoQ

Net Sales

QoQ Growth in quarter ended Mar 2026 is -13.79% vs -0.85% in Dec 2025

Consolidate Net Profit

QoQ Growth in quarter ended Mar 2026 is -81.74% vs -10.18% in Dec 2025

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Mar 2026 is -79.74% vs -6.09% in Dec 2025

Interest

QoQ Growth in quarter ended Mar 2026 is 11.97% vs 4.08% in Dec 2025

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025

Compare Quarterly Results Of Dr Reddy's Labs With

Select Peers

Figures in Cr

Consolidate Quarterly Results

Change(INR)

Change(%)

Net Sales

7,546.40

6,541.20

1,005.20

15.37%

Other Operating Income

0.00

Total Operating income

7,546.40

6,541.20

1,005.20

15.37%

Raw Material Cost

1,198.60

1,382.15

-183.55

-13.28%

Purchase of Finished goods

1,657.70

1,284.73

372.97

29.03%

(Increase) / Decrease In Stocks

356.40

-418.20

774.60

185.22%

Employee Cost

1,446.80

1,414.25

32.55

2.30%

Power Cost

0.00

Manufacturing Expenses

0.00

Selling and Distribution Expenses

0.00

Other Expenses

2,504.40

1,923.32

581.08

30.21%

Total Expenditure (Excl Depreciation)

7,163.90

5,586.25

1,577.65

28.24%

Operating Profit (PBDIT) excl Other Income

382.50

954.95

-572.45

-59.95%

Other Income

475.40

148.16

327.24

220.87%

Operating Profit (PBDIT)

857.90

1,103.11

-245.21

-22.23%

Interest

105.70

13.13

92.57

705.03%

Exceptional Items

0.00

Gross Profit (PBDT)

752.20

1,089.98

-337.78

-30.99%

Depreciation

557.10

382.92

174.18

45.49%

Profit Before Tax

199.70

707.06

-507.36

-71.76%

Tax

-21.60

156.95

-178.55

-113.76%

Provisions and contingencies

0.00

Profit After Tax

216.70

550.11

-333.41

-60.61%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

216.70

550.11

-333.41

-60.61%

Share in Profit of Associates

4.60

-7.60

12.20

160.53%

Minority Interest

0.40

-12.13

12.53

103.30%

Other related items

0.00

Consolidated Net Profit

220.90

554.64

-333.74

-60.17%

Equity Capital

83.50

161.56

-78.06

-48.32%

Face Value

1.00

2.00

0.00

Reserves

0.00

Earnings per share (EPS)

2.65

6.87

-4.22

-61.43%

Diluted Earnings per share

2.65

6.86

-4.21

-61.37%

Operating Profit Margin (Excl OI)

5.09%

14.77%

0.00

-9.68%

Gross Profit Margin

10.01%

16.86%

0.00

-6.85%

PAT Margin

2.94%

8.51%

0.00

-5.57%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 7,546.40 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is -13.79% vs -0.85% in Dec 2025

YoY Growth in quarter ended Mar 2026 is -11.51% vs 19.89% in Mar 2025

Quarterly - Consolidate Net Profit

Consolidate Net Profit 220.90 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is -81.74% vs -10.18% in Dec 2025

YoY Growth in quarter ended Mar 2026 is -86.14% vs 21.64% in Mar 2025

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 382.50 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is -79.74% vs -6.09% in Dec 2025

YoY Growth in quarter ended Mar 2026 is -80.85% vs 9.10% in Mar 2025

Quarterly - Interest

Interest 105.70 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is 11.97% vs 4.08% in Dec 2025

YoY Growth in quarter ended Mar 2026 is 61.13% vs 10.62% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 5.09%

in Mar 2026

Figures in %

QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025

YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025